Lymphoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Active, not recruiting
  • Solid Tumor
  • Lymphoma
  • CS1003 monoclonal antibody
  • Beijing, China
    Beijing Cancer Hospital
2022-01-12
Jan 12, 2022
N
Not yet recruiting
  • Lymphoma
  • PNEUMOVAX 23
  • +9 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-01-13
Jan 13, 2022
I
Recruiting
  • Multiple Myeloma
  • +17 more
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    2022-01-11
    Jan 11, 2022
    J
    Active, not recruiting
    • Lymphoma
    • New Process SHR2554 tablet、Former Process SHR2554 tablet
    • Former Process SHR2554 tablet、New Process SHR2554 tablet
    • Nanjing, Jiangsu, China
      the Affiliated Hospital of Nanjing University Medical School
    2021-12-31
    Dec 31, 2021
    A
    Not yet recruiting
    • Leukemia
    • +4 more
    • Early palliative and supportive care
    • Calgary, Alberta, Canada
      Tom Baker Cancer Centre
    2021-12-29
    Dec 29, 2021
    N
    Recruiting
    • Leukemia
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      2022-01-11
      Jan 11, 2022
      N
      Active, not recruiting
      • Melanoma
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        2022-01-11
        Jan 11, 2022
        J
        Active, not recruiting
        • Lymphoma, Non-Hodgkin
        • +9 more
        • lisocabtagene maraleucel
        • Los Angeles, California
        • +22 more
        2022-01-07
        Jan 7, 2022
        P
        Completed
        • Lymphoma
        • FDG PET/CT guided metabolic core needle biopsy
        • (no location specified)
        2021-12-29
        Dec 29, 2021
        T
        Active, not recruiting
        • Multiple Myeloma
        • +2 more
        • Atlanta, Georgia
        • +23 more
        2021-12-20
        Dec 20, 2021
        C
        Recruiting
        • Lymphoma
        • Calgary, Alberta, Canada
        • +14 more
        2022-01-10
        Jan 10, 2022
        C
        Recruiting
        • Lymphoma, Non-Hodgkin
        • +6 more
        • CB-010
        • +2 more
        • Scottsdale, Arizona
        • +5 more
        2022-01-10
        Jan 10, 2022
        N
        Completed
        • Neoplasms
        • Lymphoma
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        2022-01-07
        Jan 7, 2022
        A
        Recruiting
        • Lung Cancer
        • Lymphoma
        • DNA analysis
        • +6 more
        • La Jolla, California
        • +15 more
        2022-01-07
        Jan 7, 2022
        P
        Not yet recruiting
        • Lymphoma
        • +6 more
        • Digital Health Coaching
        • Houston, Texas
          The University of Texas MD Anderson Cancer Center
        2022-01-05
        Jan 5, 2022
        F
        Not yet recruiting
        • Clinical Stage I Cutaneous Melanoma AJCC v8
        • +33 more
        • Informational Intervention
        • +4 more
        • Los Angeles, California
        • +4 more
        2022-01-04
        Jan 4, 2022
        M
        Recruiting
        • Breast Cancer
        • +2 more
        • Cardiac Imaging
        • Data Collection
        • Montréal, Quebec, Canada
        • +1 more
        2021-12-15
        Dec 15, 2021
        U
        Terminated
        • Lymphoma
        • rituximab
        • +5 more
        • Manchester, England, United Kingdom
        • +4 more
        2021-12-16
        Dec 16, 2021